Literature DB >> 7118896

Proteoglycan carrier of human platelet factor 4. Isolation and characterization.

S S Huang, J S Huang, T F Deuel.   

Abstract

A large scale purification procedure for the human platelet factor 4 proteoglycan carrier molecule has been developed. A yield of 46% and a 33,000-fold purification have been achieved, using poly-L-lysine-Sepharose affinity column chromatography, PF4-agarose affinity column chromatography, and Bio-Gel A-0.5m gel filtration. The purified proteoglycan migrates as a single band during electrophoresis on cellulose acetate strips. A single symmetric peak was observed in sedimentation velocity analysis with an s value of 2.85. The molecular weight of the proteoglycan was determined to be 53,000 by sedimentation equilibrium. The purified proteoglycan contains 32% uronic acid, 31% galactosamine, 6.1% sulfate, and 9.9% protein. Aspartic acid, glutamic acid, leucine, glycine, and serine account for 55% of the total amino acids. The chondroitinase AC digest of the proteoglycan is sensitive to hydrolysis by chondro-4-sulfatase but not by chondro-6-sulfatase, indicating the presence of chondroitin 4-sulfate but not chondroitin 6-sulfate in the proteoglycan molecule. The interaction between this proteoglycan carrier of human PF4 and PF4 is strongly ionic strength-dependent. 0.3 M NaCl is required to dissociate the proteoglycan PF4 complex.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7118896

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Structure of the rat platelet factor 4 gene: a marker for megakaryocyte differentiation.

Authors:  T Doi; S M Greenberg; R D Rosenberg
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

2.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

Authors:  A Hildebrand; M Romarís; L M Rasmussen; D Heinegård; D R Twardzik; W A Border; E Ruoslahti
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

3.  Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.

Authors:  D M Tollefsen; C A Pestka
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

4.  Chondroitin sulphate proteoglycan in the substratum adhesion sites of Balb/c 3T3 cells. Fractionation on various ion-exchange and affinity columns.

Authors:  B C Wightman; E A Weltman; L A Culp
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

5.  Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding.

Authors:  K H Mayo; E Ilyina; V Roongta; M Dundas; J Joseph; C K Lai; T Maione; T J Daly
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

6.  Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium.

Authors:  J A Marcum; J B McKenney; R D Rosenberg
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

7.  Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.

Authors:  G P Visentin; S E Ford; J P Scott; R H Aster
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

8.  Characterization and N-terminal sequence of human platelet proteoglycan.

Authors:  J P Périn; F Bonnet; P Maillet; P Jollès
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

9.  Purification and characterization of human platelet proteoglycan.

Authors:  M Okayama; K Oguri; Y Fujiwara; H Nakanishi; H Yonekura; T Kondo; N Ui
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

10.  Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-Dependent Manner by Modulating Viral Attachment.

Authors:  Zahra F Parker; Ann H Rux; Amber M Riblett; Fang-Hua Lee; Lubica Rauova; Douglas B Cines; Mortimer Poncz; Bruce S Sachais; Robert W Doms
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-15       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.